NYSE:RFL Rafael (RFL) Stock Price, News & Analysis $2.11 +0.02 (+0.96%) Closing price 07/24/2026 03:58 PM EasternExtended Trading$2.20 +0.10 (+4.50%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Rafael Stock (NYSE:RFL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Rafael alerts:Sign Up Key Stats Today's Range$1.97▼$2.1850-Day Range$1.30▼$3.7752-Week Range$1.12▼$3.96Volume126,962 shsAverage Volume241,691 shsMarket Capitalization$109.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey. Read More Rafael Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreRFL MarketRank™: Rafael scored higher than 6% of companies evaluated by MarketBeat, and ranked 825th out of 836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingRafael has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageRafael has only been the subject of 1 research reports in the past 90 days.Read more about Rafael's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Rafael is -3.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rafael is -3.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRafael has a P/B Ratio of 1.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.72% of the float of Rafael has been sold short.Short Interest Ratio / Days to CoverRafael has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rafael has recently increased by 89.04%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRafael does not currently pay a dividend.Dividend GrowthRafael does not have a long track record of dividend growth. News and Social Media1.6 / 5News Sentiment-0.50 News SentimentRafael has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Rafael this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for RFL on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Rafael to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Rafael insiders have not sold or bought any company stock.Percentage Held by Insiders32.90% of the stock of Rafael is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions11.30% of the stock of Rafael is held by institutions.Read more about Rafael's insider trading history. Receive RFL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rafael and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RFL Stock News HeadlinesWall Street Zen Upgrades Rafael (NYSE:RFL) to "Hold"July 25 at 1:37 AM | americanbankingnews.comRafael Holdings Inc Share Price (RFL.US)July 15, 2026 | lse.co.ukAmerica Is Following in Greece's FootstepsItaly in the 90s. Argentina in 2001. Greece in 2009. America was always safe… But now the IMF is projecting that by 2031, US debt will climb to 140% of GDP. That's higher than Greece's debt was when their entire economy collapsed. When Greece broke, the EU swooped in with $300 billion in emergency bailouts. Greece was fine. But when America crosses that line? There's no one bigger to save us. We ARE the emergency bailout for the rest of the world. You can't fix $38 trillion in debt. You can't stop Congress from spending. But you CAN control how much of your wealth stays exposed to the fallout.July 26 at 1:00 AM | Decentralized Masters (Ad)Rafael Holdings Insider Trading Activity | NYSE:RFL | BenzingaJuly 2, 2026 | benzinga.comRafael Holdings: The Second Half Of Calendar 2026 Could Define This Company ForeverJune 29, 2026 | seekingalpha.comRafael Holdings (NYSE:RFL) Stock, Short Interest ReportJune 25, 2026 | benzinga.comRafael B Stock Price HistoryJune 11, 2026 | investing.comRafael Holdings, Inc. Reports Q3 Fiscal 2026 Financial Results and Progress on Phase 3 TransportNPC™ TrialJune 11, 2026 | quiverquant.comQSee More Headlines RFL Stock Analysis - Frequently Asked Questions How have RFL shares performed this year? Rafael's stock was trading at $1.1790 at the beginning of 2026. Since then, RFL shares have increased by 79.0% and is now trading at $2.11. How were Rafael's earnings last quarter? Rafael Holdings, Inc. (NYSE:RFL) announced its earnings results on Wednesday, October, 29th. The company reported ($0.28) earnings per share (EPS) for the quarter. The business earned $0.89 million during the quarter. Rafael had a negative trailing twelve-month return on equity of 41.27% and a negative net margin of 3,321.74%. How do I buy shares of Rafael? Shares of RFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Rafael own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rafael investors own include NVIDIA (NVDA), Broadcom (AVGO), CrowdStrike (CRWD), ServiceNow (NOW), Adobe (ADBE), Arista Networks (ANET) and e.l.f. Beauty (ELF). Company Calendar Last Earnings10/29/2025Today7/26/2026Fiscal Year End7/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3d) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 As of 3 days ago, RFL's financial health entered the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - DRUGS Sub-IndustryReal Estate Current SymbolNYSE:RFL CIK1713863 Webwww.rafaelholdings.com Phone(212) 658-1450FaxN/AEmployees20Year Founded2000Profitability EPS (Trailing Twelve Months)($0.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$30.52 million Net Margins-3,321.74% Pretax Margin-3,182.25% Return on Equity-41.27% Return on Assets-35.32% Debt Debt-to-Equity RatioN/A Current Ratio3.16 Quick Ratio3.14 Sales & Book Value Annual Sales$920 thousand Price / Sales119.26 Cash FlowN/A Price / Cash FlowN/A Book Value$1.91 per share Price / Book1.10Miscellaneous Outstanding Shares52,000,000Free Float34,892,000Market Cap$109.72 million OptionableOptionable Beta0.29 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NYSE:RFL) was last updated on 7/26/2026 by MarketBeat.com Staff. From Our PartnersThe comeback story of the century (ticker inside)In 2013, this struggling PC maker went private amid skepticism from Forbes and the New York Times. Instead of ...InvestorPlace | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThis tiny piece of glass could be bigger than GPUsJensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...Brownstone Research | SponsoredOxford Club Analyst’s Urgent AI WarningAlexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...The Oxford Club | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rafael Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rafael With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
